Overview
- Bloom reported blowout second‑quarter results that it released on July 28, 2026, with $1.065 billion in revenue and non‑GAAP EPS of $0.78, and management raised full‑year 2026 revenue guidance to $3.9–$4.2 billion.
- Brookfield expanded its programmatic financing from $5 billion to $25 billion and Bloom said its commercial backlog is about $20 billion, giving customers financing pathways but not eliminating delivery steps.
- The stock has surged hundreds of percent over the past year, leaving forward and trailing valuation multiples very high and trimming room for error for future quarters.
- Analysts point to clear execution risks that could derail the bull case, including the need to scale manufacturing throughput, secure critical materials, obtain site permits, manage fuel logistics, and sustain margins.
- Investors should watch whether Bloom converts backlog into timely shipments and operating cash, and whether quarterly delivery timing, margins, or permitting issues cause the stock to reprice.